ES2195122T3 - Inhibidores de metaloproteinasa. - Google Patents

Inhibidores de metaloproteinasa.

Info

Publication number
ES2195122T3
ES2195122T3 ES97912351T ES97912351T ES2195122T3 ES 2195122 T3 ES2195122 T3 ES 2195122T3 ES 97912351 T ES97912351 T ES 97912351T ES 97912351 T ES97912351 T ES 97912351T ES 2195122 T3 ES2195122 T3 ES 2195122T3
Authority
ES
Spain
Prior art keywords
metaloproteinase inhibitors
metaloproteinase
inhibitors
succinamide
carbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97912351T
Other languages
English (en)
Inventor
Raymond Paul Beckett
Mark Whittaker
Andrew Miller
Fionna Mitchell Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharmaceuticals Ltd filed Critical British Biotech Pharmaceuticals Ltd
Application granted granted Critical
Publication of ES2195122T3 publication Critical patent/ES2195122T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

N1 - [2, 2 - Dimetil - 1S - (piridin - 2 - il - carbamoil) - propil] - N4 - hidroxi - 2R - isobutil - 3S metoxi - succinamida, de fórmula (II) o una de sus sales, hidratos o solvatos farmacéuticamente aceptables.
ES97912351T 1997-11-13 1997-11-13 Inhibidores de metaloproteinasa. Expired - Lifetime ES2195122T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1997/003132 WO1999025693A1 (en) 1997-11-13 1997-11-13 Metalloproteinase inhibitors

Publications (1)

Publication Number Publication Date
ES2195122T3 true ES2195122T3 (es) 2003-12-01

Family

ID=10807699

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97912351T Expired - Lifetime ES2195122T3 (es) 1997-11-13 1997-11-13 Inhibidores de metaloproteinasa.

Country Status (21)

Country Link
EP (1) EP1030842B1 (es)
JP (1) JP2001523666A (es)
KR (1) KR100485479B1 (es)
AT (1) ATE236126T1 (es)
AU (1) AU740420B2 (es)
BR (1) BR9714934A (es)
CA (1) CA2310593C (es)
DE (1) DE69720554T2 (es)
DK (1) DK1030842T3 (es)
ES (1) ES2195122T3 (es)
GB (1) GB2333524A (es)
HU (1) HUP0002811A3 (es)
IL (1) IL135210A0 (es)
NO (1) NO315702B1 (es)
NZ (1) NZ503642A (es)
PL (1) PL189542B1 (es)
PT (1) PT1030842E (es)
RU (1) RU2198164C2 (es)
TR (1) TR200001353T2 (es)
TW (1) TW474919B (es)
WO (1) WO1999025693A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2024507C1 (ru) * 1991-11-18 1994-12-15 Евгений Яковлевич Левитин 5-хлор-2-пиридиламид-4-нитро-n-(карбоксиметил)антраниловой кислоты, проявляющий противовоспалительную активность
PT822186E (pt) * 1994-01-20 2000-08-31 British Biotech Pharm L-tert-leucina-2-piridilamida
WO1997003966A1 (en) * 1995-07-19 1997-02-06 British Biotech Pharmaceuticals Limited N-(amino acid) substituted succinic acid amide derivatives as metalloproteinase inhibitors

Also Published As

Publication number Publication date
NO20002480L (no) 2000-05-12
PL340494A1 (en) 2001-02-12
EP1030842A1 (en) 2000-08-30
DE69720554T2 (de) 2004-01-08
WO1999025693A1 (en) 1999-05-27
ATE236126T1 (de) 2003-04-15
AU740420B2 (en) 2001-11-01
CA2310593A1 (en) 1999-05-27
DE69720554D1 (de) 2003-05-08
PL189542B1 (pl) 2005-08-31
TW474919B (en) 2002-02-01
GB2333524A (en) 1999-07-28
TR200001353T2 (tr) 2000-10-23
PT1030842E (pt) 2003-07-31
KR20010031879A (ko) 2001-04-16
HUP0002811A3 (en) 2002-11-28
NZ503642A (en) 2001-10-26
NO20002480D0 (no) 2000-05-12
RU2198164C2 (ru) 2003-02-10
EP1030842B1 (en) 2003-04-02
JP2001523666A (ja) 2001-11-27
CA2310593C (en) 2007-05-08
BR9714934A (pt) 2000-10-03
AU4958497A (en) 1999-06-07
NO315702B1 (no) 2003-10-13
IL135210A0 (en) 2001-05-20
DK1030842T3 (da) 2003-07-28
GB9816317D0 (en) 1998-09-23
KR100485479B1 (ko) 2005-04-27
HUP0002811A2 (hu) 2001-01-29

Similar Documents

Publication Publication Date Title
NO331175B1 (no) Kinazolin-derivater som angiogenese-inhibitorer og mellomprodukter derav.
NO20011023L (no) Arylpiperaziner og anvendelse derav som metalloproteinase inhiberende midler (MMP)
MX9201030A (es) Inhibidores multiciclicos, poliaromaticos de escualenosintetasa de amina terciaria.
CO4750823A1 (es) Sales bisindolilmaleimidas con un puente n,n´ como inhibidores de proteina quinasa c
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
ID18142A (id) Inhibitor metaloprotease 1,4-heterosiklik
ID18141A (id) Inhibitor metaloprotease 1,3-diheterosiklik
PT1193270E (pt) Pirrolobenzodiazepinas
TR199800773T2 (xx) Trombin inhibit�rleri.
PT882024E (pt) Compostos inibidores da protease retroviral
NO994877L (no) Kalsilytiske forbindelser
IS4955A (is) Tálmar gegn frumusamloðun
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
CY1109276T1 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
NO944406L (no) Nye 7 e inhibitorer
ATE235462T1 (de) Metalloproteinase-inhibitoren
SE9601556D0 (sv) New pharmaceutical formulation of a thrombin inhibitor for parenteral use
DK1023268T3 (da) Isoquinoliner som urokinaseinhibitorer.
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
SV1998000151A (es) Compuestos de triazina
MY128164A (en) Compounds
BG104575A (en) Matrix metalloprotease inhibitors
CY1105411T1 (el) Νεα παραγωγα πλευρομουτιλινης
NO20023951L (no) Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler
AP2001002045A0 (en) FKBP inhibitors.